Pulmonx Corporation
LUNG
$3.42
$0.164.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.66% | 6.85% | 7.71% | -11.47% | 1.00% |
| Total Depreciation and Amortization | -5.44% | 169.34% | -135.33% | 183.69% | 47.39% |
| Total Amortization of Deferred Charges | 0.00% | -98.64% | -12.89% | 5,718.75% | 23.08% |
| Total Other Non-Cash Items | 6.90% | -5.96% | -6.92% | -0.50% | 10.48% |
| Change in Net Operating Assets | -706.21% | -4.36% | -37.12% | 128.34% | -996.92% |
| Cash from Operations | -96.46% | 7.07% | -25.51% | 51.08% | -39.60% |
| Capital Expenditure | -171.17% | 73.32% | 11.30% | -3.99% | -125.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.18% | 97.82% | 2,058.20% | 82.20% | 19.53% |
| Cash from Investing | 15.97% | 108.37% | 908.50% | 66.69% | 9.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 498.20% | -75.82% | 1,812.50% | -97.22% | 1,250.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 970.97% | -86.49% | 2,186.36% | -102.55% | 4,982.35% |
| Foreign Exchange rate Adjustments | -154.40% | 262.18% | -158.70% | -195.83% | 122.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.92% | 5,127.81% | 97.74% | 50.16% | -17.49% |